Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study

• Published in: International journal of infectious diseases Vol. 116; pp. 167 - 173
• Main Authors: McKinnon, John E., Wang, Dee Dee, Zervos, Marcus, Saval, Matt, Marshall-Nightengale, Laurie, Kilgore, Paul, Pabla, Pardeep, Szandzik, Ed, Maksimowicz-McKinnon, Kathleen, O'Neill, William W.
• Format: Journal Article
• Language: English
• Published: Canada Elsevier Ltd 01.03.2022; Elsevier
• Subjects: Chemoprophylaxis; COVID-19; COVID-19 - drug therapy; COVID-19 - prevention & control; Emergency Responders; Health care workers; Health Personnel; Humans; Hydroxychloroquine; Hydroxychloroquine - adverse effects; Prospective Studies; Randomized trial; SARS-CoV-2; Treatment Outcome; COVID-19; Health care workers; Chemoprophylaxis; Randomized trial; Hydroxychloroquine

•Hydroxychloroquine chemoprophylaxis is safe in high-risk populations for COVID-19.•No increased cardiovascular risks were observed with hydroxychloroquine chemoprophylaxis.•Adverse events were similar between placebo and hydroxychloroquine treatment arms. Health care workers (HCW) are among the hig...